These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 26304878)
1. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance. Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878 [TBL] [Abstract][Full Text] [Related]
2. Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer. Lin CC; Bruinooge SS; Kirkwood MK; Hershman DL; Jemal A; Guadagnolo BA; Yu JB; Hopkins S; Goldstein M; Bajorin D; Giordano SH; Kosty M; Arnone A; Hanley A; Stevens S; Olsen C Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):719-28. PubMed ID: 26972644 [TBL] [Abstract][Full Text] [Related]
3. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547 [TBL] [Abstract][Full Text] [Related]
5. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer. Panchal JM; Lairson DR; Chan W; Du XL Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529 [TBL] [Abstract][Full Text] [Related]
6. Association between travel distance and metastatic disease at diagnosis among patients with colon cancer. Massarweh NN; Chiang YJ; Xing Y; Chang GJ; Haynes AB; You YN; Feig BW; Cormier JN J Clin Oncol; 2014 Mar; 32(9):942-8. PubMed ID: 24516014 [TBL] [Abstract][Full Text] [Related]
7. Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients. Weeks KS; Lynch CF; West M; Carnahan R; O'Rorke M; Oleson J; McDonald M; Stewart SL; ; Charlton M Gynecol Oncol; 2022 Jan; 164(1):3-11. PubMed ID: 34776243 [TBL] [Abstract][Full Text] [Related]
8. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531 [TBL] [Abstract][Full Text] [Related]
9. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer. Murphy CC; Harlan LC; Warren JL; Geiger AM J Clin Oncol; 2015 Aug; 33(23):2530-6. PubMed ID: 26150445 [TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer surgery in Arizona: a statewide analysis of access to care. Benjamin I; Dalton H; Qiu Y; Cayco L; Johnson WG; Balducci J Gynecol Oncol; 2011 Apr; 121(1):83-6. PubMed ID: 21208650 [TBL] [Abstract][Full Text] [Related]
11. Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States. Hao S; Snyder RA; Irish W; Parikh AA PLoS Med; 2021 Oct; 18(10):e1003842. PubMed ID: 34695123 [TBL] [Abstract][Full Text] [Related]
12. Association between the availability of medical oncologists and initiation of chemotherapy for patients with stage III colon cancer. Lin CC; Virgo KS J Oncol Pract; 2013 Jan; 9(1):27-33. PubMed ID: 23633968 [TBL] [Abstract][Full Text] [Related]
13. Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility. Gray PJ; Lin CC; Sineshaw H; Paly JJ; Jemal A; Efstathiou JA Cancer; 2015 Mar; 121(5):681-7. PubMed ID: 25345675 [TBL] [Abstract][Full Text] [Related]
14. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study. Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127 [TBL] [Abstract][Full Text] [Related]
15. Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes. Xu Z; Becerra AZ; Justiniano CF; Boodry CI; Aquina CT; Swanger AA; Temple LK; Fleming FJ Dis Colon Rectum; 2017 Dec; 60(12):1250-1259. PubMed ID: 29112560 [TBL] [Abstract][Full Text] [Related]
16. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal. Gilbar P; Lee A; Pokharel K J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241 [TBL] [Abstract][Full Text] [Related]
17. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer. Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308 [TBL] [Abstract][Full Text] [Related]
18. Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. Shea AM; Curtis LH; Hammill BG; DiMartino LD; Abernethy AP; Schulman KA JAMA; 2008 Jul; 300(2):189-96. PubMed ID: 18612116 [TBL] [Abstract][Full Text] [Related]
19. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806 [TBL] [Abstract][Full Text] [Related]
20. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana. Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]